IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Innate Immunotherapeutics LTD

CUSIP: ACI11Y0R8 | 1 institutional holders

Quarters

Q1 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2018

QCI Asset Management Inc450,000
0.0% of portfolio›$26
StyleTurnoverLocationFiled
QCI Asset Management Inc
450,000$260.0%N/AN/APittsford, NY2018-05-03